ArticleAnnals of surgical oncology2023

Timing is Everything: Neoadjuvant Versus Adjuvant Immunotherapy in Patients with Resectable Metastatic Melanoma.

Ashley M Holder et al.PubMed ↗Publisher ↗

No numbers read from the abstract.